CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 51 - 60 of 820
Study Number Lead Group Study Title CIRB Study Status
10186 ETCTN A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma Adult CIRB - Early Phase Emphasis Available to Open
10191 ETCTN A Phase 2 Study of M6620 in Combination with Carboplatin compared with Docetaxel in Combination with Carboplatin in Metastatic Castration-Resistant Prostate Cancer Adult CIRB - Early Phase Emphasis Available to Open
10193 ETCTN Phase 2 Study of Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-cell Lymphoma and Primary Mediastinal Large B-cell Lymphoma Adult CIRB - Early Phase Emphasis Available to Open
10195 ETCTN A Phase 2 Study of Copanlisib (BAY 80-6946) in Combination with Fulvestrant in Women with Metastatic Breast Cancer Progressing After Aromatase Inhibitor Plus CDK 4/6 Inhibitor Adult CIRB - Early Phase Emphasis Available to Open
10200 ETCTN Combination Pinometostat and 5-Azacitidine for the Treatment of Patients with Relapsed / Refractory Acute Myeloid Leukemia, or Newly Diagnosed Patients Who are Ineligible for or Unwilling to Undergo Intensive Therapy, Who Harbor an 11q23 Rearrangement Adult CIRB - Early Phase Emphasis Available to Open
10204 ETCTN A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO) Adult CIRB - Early Phase Emphasis Available to Open
10208 ETCTN A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody, or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma Adult CIRB - Early Phase Emphasis Available to Open
10211 ETCTN A Phase 2 Single-Arm Study of M6620 in Combination with Irinotecan in Patients with Progressive TP53 Mutant Gastric and Gastro-Esophageal Junction Cancer Adult CIRB - Early Phase Emphasis Available to Open
10212 ETCTN A Phase 1b/2 study of Pinometostat in Combination with standard induction chemotherapy in newly diagnosed Acute Myeloid Leukemia with MLL rearrangement Adult CIRB - Early Phase Emphasis Available to Open
10214 ETCTN Immune Checkpoint Blockade for Kidney Transplant Recipients with Selected Unresectable or Metastatic Cancers Adult CIRB - Early Phase Emphasis Available to Open
Displaying 51 - 60 of 820